ANNEXSupplementary provisions
ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 11, Bentazone, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (2) in the sixth column, expiration of approval, of row 15, Diquat, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (3) in the sixth column, expiration of approval, of row 17, Thiabendazole, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (4) in the sixth column, expiration of approval, of row 19, DPX KE 459 (flupyrsulfuron-methyl), the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (5) in the sixth column, expiration of approval, of row 23, Pymetrozine, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (6) in the sixth column, expiration of approval, of row 26, Thifensulfuron-methyl, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (7) in the sixth column, expiration of approval, of row 31, Prosulfuron, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (8) the sixth column, expiration of approval, of row 34, Cyhalofop butyl, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (9) in the sixth column, expiration of approval, of row 35, Famoxadone, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (10) in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (11) in the sixth column, expiration of approval, of row 38, Picolinafen, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’; (12) in the sixth column, expiration of approval, of row 39, Flumioxazine, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’.